MedTrace Logo

Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain

NCT05087277 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2021-10-21

No results posted yet for this study

Summary

The level of neutralizing antibody was detected by using the constructed pseudovirus covid-19 variant at baseline , 1 month , 6 months and 12 months after primary vaccination, within 15 days after booster immunization at 12 months . and the ability of IgG subclasses to neutralize and cross immunization of variant strains was analyzed.

Conditions

Sponsors & Collaborators

  • Centers for Disease Control and Prevention, China

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2021-10-10
Completion
2021-10-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05087277 on ClinicalTrials.gov